96
Participants
Start Date
March 21, 2024
Primary Completion Date
March 31, 2026
Study Completion Date
April 30, 2026
OATD-01
OATD-01 is an oral inhibitor of chitinase-1 (CHIT1)
Placebo
Matching placebo tablets
RECRUITING
Molecure Investigative Site, Oslo
RECRUITING
Molecure Investigative Site, Bergen
RECRUITING
Molecure Investigative Site, Vejle
RECRUITING
Molecure Investigative Site, Philadelphia
RECRUITING
Molecure Investigative Site, Baltimore
NOT_YET_RECRUITING
Molecure Investigative Site, Pátrai
RECRUITING
Molecure Investigative Site, Charleston
RECRUITING
Molecure Investigative Site, Montpellier
RECRUITING
Molecure Investigative Site, Birmingham
RECRUITING
Molecure Investigative Site, Cleveland
RECRUITING
Molecure Investigative Site, Essen
WITHDRAWN
Molecure Investigative Site, Corfu
RECRUITING
Molecure Investigative Site, Mainz-GE
WITHDRAWN
Molecure Investigative Site, Rochester
RECRUITING
Molecure Investigative Site, Thessaloniki
WITHDRAWN
Molecure Investigative Site, Kansas City
RECRUITING
Molecure Investigative Site, Heraklion
RECRUITING
Molecure Investigative Site, Paris
RECRUITING
Molecure Investigative Site, Paris
RECRUITING
Molecure Investigative Site, Freiburg im Breisgau
WITHDRAWN
Molecure Investigative Site, Bobigny
NOT_YET_RECRUITING
Molecure Investigative Site, Nieuwegein
NOT_YET_RECRUITING
Molecure Investigative Site, Rotterdam
RECRUITING
Molecure Investigative Site, Birmingham
RECRUITING
Molecure Investigative Site, Cambridge
RECRUITING
Molecure Investigative Site, Edinburgh
RECRUITING
Molecure Investigative Site, London
RECRUITING
Molecure Investigative Site, London
Lead Sponsor
Molecure S.A.
INDUSTRY